---
provider: openai
model: o3-deep-research-2025-06-26
cached: true
start_time: '2025-11-03T21:37:03.957008'
end_time: '2025-11-03T21:37:03.959254'
duration_seconds: 0.0
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: P15941
  gene_symbol: MUC1
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    temperature: 0.1
    top_p: 1.0
citation_count: 155
---

## Question

# Gene Research for Functional Annotation

Please provide a comprehensive research report on the gene MUC1 (P15941) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function. 

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# Overview of MUC1 (Mucin-1) in Humans

**MUC1 (mucin-1)** is a human gene encoding a **transmembrane glycoprotein** of the mucin family. MUC1 is characterized by extensive **O-linked glycosylation** and a high molecular weight core protein (120–225 kDa, reaching 250–500 kDa with glycosylation) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14)). It is a single-pass type I membrane protein that undergoes autoproteolytic cleavage into two subunits: an extracellular **N-terminal subunit (MUC1-N)** and a smaller **C-terminal subunit (MUC1-C)** comprising a short external peptide, a transmembrane segment, and a cytoplasmic tail ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight)). These subunits remain non-covalently associated at the cell surface as a heterodimer ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight)). The MUC1 gene is located on chromosome 1q22 and is thought to have evolved from a secreted mucin gene (MUC5B) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%2C%20which%20is%20localized%20to,C)). MUC1’s extracellular domain contains a **variable number tandem repeat (VNTR)** region (20-amino-acid tandem repeats, 25–125 copies) rich in serine, threonine, and proline that carry dense O-glycans ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of)). These glycosylated repeats account for 50–90% of the protein’s mass and form a rigid, “**tower-like**” structure extending 200–500 nm above the cell surface ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=amino%20acids%20in%20length%2C%20tethers,kinase%20%28Kato%20et)). Immediately downstream of the tandem repeats is a conserved SEA domain (sea-urchin sperm protein, enterokinase, agrin) that undergoes **autoproteolysis** at a GSVVV motif, splitting the protein into MUC1-N and MUC1-C ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by)). The subunit MUC1-C consists of a 28-amino-acid transmembrane helix and a 72-amino-acid **cytoplasmic tail**, which is highly conserved across species ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000)). The cytoplasmic tail contains seven tyrosine residues and multiple serine/threonine sites that serve as docking sites for intracellular signaling proteins when phosphorylated ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). Importantly, the MUC1 protein is **polymorphic** due to VNTR length variation and alternative splicing, but the transmembrane and cytoplasmic regions are largely invariant, underscoring their critical functional roles ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20polymorphic%20transmembrane,1)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=determines%20the%20speciffic%20spatial%20structure,8)).

# Localization and Expression 

MUC1 is predominantly expressed at the **apical surface of epithelial cells** in a wide range of tissues, including the **gastrointestinal tract, respiratory tract, urogenital tract, breast, pancreas, and others** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4)). In normal epithelia, MUC1 shows a polarized distribution, being confined to the lumen-facing membrane where it contributes to the **extracellular glycocalyx** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC16%2C%20MUC17%2C%20MUC21%2C%20and%20MUC22%29.,12)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14)). It is notably absent from tissues like skin epidermis and mesenchymal cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4)), reflecting its specialized role in mucosal interfaces. At the cell surface, the large extracellular MUC1-N subunit protrudes outward and is heavily glycosylated, whereas the MUC1-C subunit spans the membrane and has a short external piece plus a cytosolic tail. This **topology** allows MUC1 to function both **outside the cell and within the cell**: the **extracellular domain** interacts with the environment (microbes, molecules, neighboring cells), and the **cytoplasmic tail** engages in intracellular signaling. MUC1 is anchored to the plasma membrane, but its extracellular component can be **shed**. Proteolytic enzymes (e.g. ADAM17/TACE or metalloproteases) can cleave within the SEA domain to release the large MUC1-N subunit from the cell surface ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Ligtenberg%20et%20al,2004%3B%20Thathiah%20and%20Carson)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=TNF,Lind%C3%A9n%20et%20al)). Shedding of MUC1 is often stimulated by cell stress or inflammation and results in the shed mucin becoming part of the soluble mucus layer. The remaining MUC1-C fragment stays in the membrane and can be endocytosed and recycled to the surface ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%29,2000)). In addition, evidence suggests that the MUC1-C subunit can undergo further proteolysis by **γ-secretase**, releasing the cytoplasmic tail into the cytosol ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells)). This released tail has been observed to **translocate to the nucleus** in some contexts, especially in cancer cells, where it can influence gene transcription ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151)). Thus, MUC1’s localization is dynamic: it primarily resides on the cell membrane at the cell-exterior interface, but fragments can localize to the **extracellular milieu** (shed ectodomain), **endosomal compartments** (during recycling), and even the **nucleus** (intracellular domain in certain signaling events).

# Protective Barrier Function

One of the primary physiological roles of MUC1 is to **protect and lubricate mucosal surfaces**. As a **cell-surface mucin**, MUC1 contributes to the formation of a **protective barrier** on epithelial cells that face external environments ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition)). The dense sugar-coated tandem repeats give MUC1 a hydrated, gel-like character that helps trap water and form mucus, preventing desiccation and mechanical damage to epithelia. MUC1 and other mucins line the **respiratory airways, gastrointestinal tract, and urogenital tract**, where they form part of the first line of defense against pathogens ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Introduction)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,9)). Because of its towering length (~200–500 nm) above the cell surface, MUC1 can sterically hinder microorganisms from reaching the cell membrane ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20family%20of%20cell%20surface,may%20play%20an%20important%20biological)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20all%20of%20the,The%20extracellular%20region%20that%20is)). In essence, pathogens encounter a “forest” of mucin molecules that block access to underlying receptors on the epithelial surface. 

Moreover, **MUC1 can function as a releasable decoy for pathogens**. The extracellular domain of MUC1 provides binding sites (glycan epitopes) that many bacteria and viruses adhere to ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=surface%20by%20nearly%20all%20epithelial,most%20extensively%20studied%20of%20the)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=environment%2C%20MUC1%20has%20been%20demonstrated,mucin%20regulates%20inflammation)). Upon binding of a microbe, MUC1-N can be shed from the cell surface (through the SEA-domain cleavage or protease action), carrying away the bound pathogen in the shed mucus ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Thathiah%20et%20al,2009)). This mechanism helps clear pathogens from the surface: for example, when **Helicobacter pylori** binds to MUC1 on gastric cells, it triggers MUC1’s auto-cleavage and shedding, thereby removing the bacterium from the cell interface ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%3B%20Vinall%20et%20al,2007)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016)). In mouse models, the importance of MUC1 in pathogen defense is evident. **Muc1-knockout mice** show increased susceptibility to certain infections: in one study, Muc1-deficient mice had greater gastrointestinal colonization and inflammation from *Campylobacter jejuni*, demonstrating that MUC1 normally limits *C. jejuni* spread and dampens gut inflammation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=gastrointestinal%20and%20systemic%20spread%20of,another%20gastrointestinal%20pathogen%2C%20enteroaggregative%20Escherichia)). Similarly, MUC1 on gastric mucosa and even on immune cells helps restrict *H. pylori* infection; mice lacking Muc1 had higher stomach colonization, and human studies found that individuals with genetically shorter MUC1 VNTR alleles (producing a smaller extracellular domain) are at higher risk for *H. pylori*-associated gastritis and cancer ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Wotherspoon%20et%20al,ED)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016)). These findings underscore MUC1’s role as a **physical barrier and microbial decoy**, protecting the host by binding pathogens and facilitating their removal.

Beyond bacteria, MUC1 also interferes with viruses and other particles. For instance, in the respiratory tract MUC1 can bind the flagellin of *Pseudomonas aeruginosa*, acting as an attachment site ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection)). Interestingly, while this binding could help immobilize the bacteria, **excess MUC1 in airway infections can sometimes dampen clearance**. In a *P. aeruginosa* lung infection model, wild-type mice (with MUC1) had higher bacterial burdens than Muc1-knockout mice ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection)). The absence of MUC1 led to a more vigorous early inflammatory response that cleared the bacteria faster ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection)). This paradox is explained by MUC1’s secondary role in modulating inflammation (see below): MUC1 can suppress excessive inflammatory signals, which in the lung can lead to reduced early clearance of bacteria ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1)). Nonetheless, in general, MUC1’s presence on mucosal surfaces is considered protective, reducing pathogen adhesion in contexts like the gut and serving as part of the **mucosal immune barrier**. It also contributes to the **lubrication** of epithelial linings, as its gel-like extracellular domain helps mucus flow. This lubricating function is crucial in organs like the **mouth and gastrointestinal tract** (aiding the passage of food) and the **bladder** (protecting urothelium from urine) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications)).

# Regulation of Cell Adhesion and Epithelial Integrity

MUC1 also influences **cell–cell and cell–matrix adhesion**, due in part to its bulky extracellular domain. In normal epithelia, MUC1 is thought to provide an **anti-adhesive shield** on the apical surface – its dense glycan chains can impede interactions between the cell and other cells or microbes. This helps prevent unwanted adhesion of pathogens, but it also means MUC1 can reduce cell–cell contacts on the apical side, potentially facilitating cell turnover and migration in tissues ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,studies%20have%20shown%20that%20MUC1)). In polarized epithelial sheets, lateral junctions (like E-cadherin-based adherens junctions) are usually protected from MUC1’s interference by the restricted apical localization. However, if MUC1 loses its polarized distribution (as can occur in injury or carcinoma), its presence over the entire cell surface can disrupt cell adhesion. The large extracellular domain can sterically hinder adhesion receptors such as cadherins and integrins, thereby **reducing cell aggregation** and promoting a motile, invasive phenotype ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)). This phenomenon is especially noted in cancer: tumor cells often overexpress MUC1 and mis-localize it across the cell membrane, which can **impair cell–cell cohesion** and enhance detachment and metastasis ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=interactions%20with%20cell%20surface%20receptors,monoclonal%20antibody%20TAB004%20overcomes%20anoikis)). For example, elevated MUC1 on carcinoma cells correlates with an inability of E-cadherin to form tight junctions, partly because MUC1’s extracellular domain physically blocks close cell-cell apposition. Thus, in a normal setting MUC1 helps delineate the apical surface and prevent inappropriate adhesion, while in pathological contexts its anti-adhesive property contributes to **loss of epithelial integrity**.

Notably, the cytoplasmic tail of MUC1 can also interact with the cell’s structural machinery. MUC1’s intracellular domain associates with β-catenin – a key component of adherens junctions and the Wnt signaling pathway ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). In normal cells, this interaction might sequester some β-catenin at the cell membrane or cytosol, affecting adhesion complexes. In cancer cells, evidence suggests MUC1-C sequesters β-catenin and can even help transport it to the nucleus, thereby **activating Wnt target genes** that promote epithelial–mesenchymal transition (EMT) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated)). A study in renal carcinoma showed MUC1-C drives EMT through β-catenin signaling and activation of EMT transcription factors (e.g. Snail) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated)). By modulating such partners, MUC1 can influence cytoskeletal organization and cell morphology during migration and wound healing. Indeed, MUC1 has been implicated in **epithelial repair processes**: after injury, MUC1 levels rise, and it may participate in EMT and cell migration to cover wounds ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=extracellular%20domain%2C%20a%2028,cancer%20cases%20exhibiting%20its%20abnormal)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=MUC1%20serves%20as%20a%20protective,C%20participates%20in)). This role in regeneration aligns with observations that MUC1 can be induced by factors like TGF-β or hypoxia, which are involved in EMT and tissue remodeling ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,a%20crucial%20role%20in%20RCC)). In summary, MUC1 acts as a modulator of adhesion – maintaining **epithelial barrier integrity** when properly localized, but when dysregulated, contributing to **cell detachment and EMT**.

# Signaling Roles and Pathway Involvement

Although MUC1 was long viewed as a passive barrier molecule, research has revealed that its **C-terminal cytoplasmic tail actively participates in cell signaling**. The 72-amino-acid MUC1 cytoplasmic tail (MUC1-CT) contains multiple conserved motifs that become phosphorylated by kinases and serve as docking sites for signaling proteins ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). This allows MUC1 to function as a **signaling adaptor or scaffold** that can influence various biochemical pathways:

- **Growth Factor and Kinase Signaling:** MUC1-CT interacts with several oncogenic signaling proteins. For example, it can bind the **epidermal growth factor receptor (EGFR)** and src-family kinases, and it contains an SH2-binding motif that recruits the adaptor **Grb2** when a specific tyrosine is phosphorylated ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2001a%20%29%3B%20PLC,29)). Through Grb2 and the adaptor **Shc**, MUC1 can link to the Ras–MAPK pathway ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al)). MUC1 also associates with **phosphoinositide 3-kinase (PI3K)**, likely via the PI3K p85 subunit’s SH2 domain, to modulate the PI3K–AKT survival pathway ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al)). These interactions suggest that when a growth factor stimulus (such as EGF) occurs, MUC1 gets phosphorylated (e.g., by EGFR or Src) and then helps propagate signals that promote cell proliferation or survival ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing)). Indeed, experiments have shown that EGF binding to EGFR leads to MUC1 tail phosphorylation, enabling binding of Grb2 and activation of downstream mitogenic signaling ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=protein%20kinase,2007)). Thus, MUC1 can augment signals from growth factor receptors and integrate into classic pathways like **Ras/MAPK and PI3K/AKT**.

- **Wnt/β-Catenin Pathway:** MUC1’s interaction with **β-catenin** is a well-documented example of its signaling role. β-Catenin is involved in cell–cell adhesion (at E-cadherin junctions) and in Wnt signaling (as a transcriptional co-activator in the nucleus). MUC1-CT binds β-catenin on the same armadillo repeat region that E-cadherin binds ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). In carcinoma cells, overexpressed MUC1 can compete with E-cadherin, sequestering β-catenin away from cell junctions ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). The MUC1–β-catenin complex can then translocate to the nucleus. Studies by Yamamoto et al. and others found that MUC1’s tail, once phosphorylated, forms a complex with β-catenin and potentiates β-catenin’s ability to activate Wnt target genes, such as **cyclin D1 and c-Myc**, promoting cell cycle progression ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated)). This positions MUC1 as an **influencer of the Wnt pathway**, particularly in oncogenic contexts. Consistent with this, MUC1-C has been shown to drive EMT and invasiveness via Wnt/β-catenin signaling in cancer models ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated)).

- **NF-κB and Inflammation Signaling:** The MUC1 cytoplasmic tail has been reported to interact with the **NF-κB pathway**. In inflammatory environments, MUC1-C can translocate to the nucleus and bind the p65 subunit of NF-κB, a transcription factor controlling many immune and survival genes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151)). One study in prostate cancer found MUC1-C/p65 complexes on chromatin, leading to increased expression of genes like **ZEB1 and EZH2** that drive EMT and stemness ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151)). By serving as a co-factor for NF-κB, MUC1 may amplify or sustain the transcription of specific target genes. In general, MUC1’s ability to modulate NF-κB and other transcription factors links it to pathways of **inflammation, apoptosis, and cell survival**.

- **Intrinsic Apoptotic Pathways:** Emerging evidence suggests MUC1-C can localize to mitochondria and affect apoptosis. The C-terminal subunit has been detected on the outer mitochondrial membrane in some cancer cells, where it interferes with pro-apoptotic signaling. For instance, MUC1 has been reported to block the release of mitochondrial apoptogenic factors (like cytochrome c) upon drug treatment, thereby conferring **chemotherapy resistance** by inhibiting apoptosis ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=promoting%20its%20degradation%20%2817%20%29,25)). This is not a classical signaling pathway, but it illustrates MUC1’s multifunctional role in cell survival mechanisms.

- **Other interactions:** MUC1-CT binds to various other molecules: it can associate with **GSK3β** (a kinase in Wnt and other pathways), **Protein kinase Cδ**, and elements of T-cell signaling like ZAP-70 and Lck in immune cells ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=Blue%20bars%20mark%20the%20known,the%20CT%20contains%20the%20motif)). Many of these interactions depend on specific phosphorylation of MUC1 tyrosines. For example, phosphorylation on distinct tyrosines creates binding sites for either β-catenin or PI3K or Src-homology domains, allowing MUC1 to act as a platform for signaling complexes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al)). The **CQC motif** at the very end of the cytoplasmic tail is required for MUC1’s proper localization and perhaps its dimerization; mutation of this CQC motif disrupts MUC1 targeting to the membrane and attenuates its signaling functions ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007)). This motif includes cysteine residues that are palmitoylated, anchoring MUC1-C in lipid rafts at the plasma membrane ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007)). Loss of these modifications can send MUC1 to other cellular locations and alter signal outputs.

Overall, through its cytoplasmic tail, MUC1 **integrates into multiple signaling networks**. Under normal conditions, these interactions may help fine-tune epithelial responses to growth factors, stress, or inflammatory signals. In disease states (especially cancer), the same signaling roles of MUC1 are often co-opted to promote unchecked proliferation, survival, and metastasis.

# Modulation of Inflammation and Immune Response

MUC1 plays a significant role in regulating **immune responses** at mucosal surfaces. Not only does it act as a physical barrier to pathogens, it also functions as a **negative regulator of pathogen-induced signaling**, preventing excessive inflammation. The cytoplasmic tail of MUC1 has been shown to interact with pattern recognition receptor signaling, especially **Toll-like receptors (TLRs)** on immune and epithelial cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=inflammation,with%20TLRs%20at%20the%20cell)). When a pathogen is detected, TLRs typically activate NF-κB and other pathways to induce pro-inflammatory cytokines. MUC1 is unusual in that it is **upregulated by inflammatory stimuli** (such as tumor necrosis factor alpha, TNF-α, or pathogen components) and then acts in a feedback manner to dampen the inflammatory response ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell)). 

Several studies illustrate MUC1’s anti-inflammatory role: for example, binding of *Pseudomonas* flagellin to cell-surface MUC1 triggers phosphorylation of the MUC1-CT (via EGFR), allowing the MUC1 tail to associate with **TLR5** and block MyD88 recruitment ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)). MyD88 is the adaptor protein needed for downstream TLR signaling, so MUC1 essentially **competitively inhibits TLR signaling** in this context ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)). Kato et al. (2012) demonstrated that in airway epithelial cells, this mechanism reduced activation of the NF-κB pathway and lowered production of IL-8 and TNF-α during *P. aeruginosa* infection ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)). Similarly, MUC1-CT can interact with **TLR3** (the receptor for viral double-stranded RNA) and prevent the adapter TRIF from binding, thereby suppressing the type I interferon response and cell death triggered by viral RNA sensing ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence)). This was shown using synthetic dsRNA (poly I:C) in lung epithelial models, where wild-type cells (with MUC1) had milder cytokine responses and apoptosis compared to cells lacking the MUC1 tail ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence)). 

Broadly, MUC1 seems to serve as a **universal attenuator of TLR signaling**. Ueno et al. (2008) tested various TLR agonists (for TLR2, 3, 4, 7, 9) and found that the presence of MUC1-CT was required to limit the inflammatory response to each of these stimuli ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating)). In macrophages or monocytes, which also express MUC1, the MUC1-CT similarly reduces pro-inflammatory cytokine release upon challenge ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=including%20Pam_,CT%20is%20required%20for%20the)). There is evidence linking MUC1’s anti-inflammatory effects with induction of **IL-10** (an anti-inflammatory cytokine) and interferons, suggesting MUC1 might skew responses toward resolution of inflammation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Kato%20et%20al,role%20in%20controlling%20disease%20severity)). Furthermore, because TLR-driven inflammation is a prerequisite for inflammasome activation, MUC1’s braking effect on TLRs also means it can indirectly **suppress inflammasome pathways** (reducing maturation of IL-1β and IL-18) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=formation%20of%20the%20inflammasome%20complex,as%20the%20NLRP%2C%20or%20the)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Figure%202B%29,Figure%202C)). This helps prevent overactivation of immune responses that could damage tissue.

In essence, MUC1 provides a check on the innate immune system: it allows initial pathogen sensing, but as infection proceeds, increased MUC1 on the cell surface helps **prevent an overzealous inflammatory reaction** that can harm host tissues ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell)). This modulator function is beneficial in preventing chronic inflammation and tissue injury. However, it can be a double-edged sword; as noted earlier, in acute infections like *P. aeruginosa* pneumonia, MUC1’s suppression of inflammation can slow bacterial clearance ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1)). The overall effect of MUC1 on immunity appears context-dependent – balancing pathogen clearance with prevention of immunopathology. This role is conserved across species (the cytoplasmic tail is homologous from humans to mammals like mice ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000))), highlighting its importance in immune homeostasis.

# Clinical Significance and Applications

MUC1’s distinctive features in normal and disease states have made it a focus of clinical interest, especially in **cancer diagnosis and therapy**. In healthy tissue, MUC1 is mostly confined to the apical surface of epithelial cells and carries long, complex glycan chains. In many **epithelial cancers**, MUC1 is **overexpressed** and abnormally glycosylated, and it loses its polarized distribution ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)). Over 90% of human **breast carcinomas** overexpress MUC1, often to a very high level ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)). Similar overexpression is observed in other adenocarcinomas (e.g. ovarian, lung, pancreatic, prostate), where MUC1 is found across the entire cell surface and even in circulation as shed fragments. Tumor-associated MUC1 typically has shorter glycans (due to altered glycosyltransferase activity in cancers), exposing cryptic peptide epitopes and carbohydrate antigens (such as the **Tn, sTn, and T antigen** clusters) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=In%20cancer%20cells%2C%20the%20long,Friedenreich%2C%20CD176%2C%20T%20antigen%29%2C%20and)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,10%E2%80%9312)). These tumor-specific epitopes make MUC1 a useful **biomarker** and an immunotherapeutic target. For instance, the serum **CA15-3 test** for breast cancer monitors circulating MUC1 fragments carrying the cancer-associated sialyl-T antigen. An abnormally high level of MUC1 in patient serum can indicate tumor burden and is used in monitoring breast cancer progression or recurrence ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC)). 

Clinically, MUC1 expression correlates with disease outcomes. **Abnormally high MUC1 levels are associated with poor prognosis** in multiple cancers, including breast, lung, pancreatic, renal, and others ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,pancreatic%20ductal%20carcinoma%2C%20and%20thymic)). The presence of MUC1 contributes to tumor progression by enhancing proliferation, invasion, and immune evasion ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)). MUC1 functions as an **oncoprotein** in these settings – for example, MUC1 can drive cancer cell growth by activating pro-tumorigenic pathways (Wnt/β-catenin, NF-κB, etc.) and conferring resistance to apoptosis and therapy ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can)). Due to this central role, MUC1 was ranked the **second most promising cancer antigen** (out of 75) by an NIH-led consortium for developing cancer immunotherapies ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=strong%20antitumor%20effects,in%20cancer%20research%20by%20the)). This has spurred numerous efforts to target MUC1 in cancer treatment.

**Cancer vaccines targeting MUC1** are one active area of research. MUC1’s immunogenic VNTR domain (with repetitive peptide epitopes) can be used to raise antibodies and T-cells. In fact, MUC1 was one of the first tumor antigens tested in vaccine trials. Various vaccine formulations – from synthetic MUC1 peptides conjugated to carriers, to dendritic cells loaded with MUC1 antigen, to viral vector vaccines encoding MUC1 – have been developed ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=In%20recent%20years%2C%20new%20discoveries,manner%2C%20with%20objective%20remission%20being)). As an example, **TG4010** is a modified vaccinia Ankara (MVA) virus vaccine that delivers the human MUC1 gene plus IL-2; it has been tested in **phase I/II trials** for cancers like non-small cell lung cancer and showed a favorable safety profile ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=TG4010%20is%20a%20cancer%20vaccine,In%20metastatic%20RCC)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=telomerase%2C%20survivin%2C%20and%20MAGE,like%20receptor%209%20%28TLR9%29%20agonist)). In a clinical study for metastatic renal cancer, an RNA vaccine including MUC1 (among other tumor antigens) induced MUC1-specific T-cell responses in patients, with some experiencing stable disease or partial remission ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=detected%20in%20the%2011%20patients,133%5D%20demonstrated%20that)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=CD4,like%20receptor%209%20%28TLR9%29%20agonist)). Another approach used autologous dendritic cells pulsed with a MUC1 peptide (containing a helper T-cell epitope PADRE) in renal carcinoma, resulting in cytotoxic T-cells that could kill MUC1-expressing tumor cells and minor tumor regressions in a subset of patients ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=development%20of%20research%20strategies%20targeting,patients%20with%20metastatic%20RCC%20to)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%28DC,A1%29%20using%20adjuvant%20granulocyte%E2%80%93macrophage%20colony)). These early-phase trials affirm that MUC1 vaccines can safely generate an immune response. More recently, **liposomal MUC1 glycopeptide vaccines** (like L-BLP25) were tested in lung cancer, and **MUC1 peptide conjugates** are under investigation for breast and prostate cancer immunoprevention ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20CAR,NCT00852007)).

**Antibody-based therapies** targeting MUC1 are also being explored. Monoclonal antibodies that recognize tumor-specific MUC1 epitopes (for example, the antibody **TAB004** that binds a cancer-specific glycoform of MUC1) have shown promising preclinical results – binding to tumor cells and inducing their destruction ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=stemness%20of%20cancer%20cells%2C%20primarily,As%20an%20oncogenic%20driver%2C%20MUC1)). MUC1-directed antibody–drug conjugates (ADCs) are in development, in which an anti-MUC1 antibody delivers a cytotoxic drug to MUC1-expressing tumor cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=tandem%20repeats%20%28VNTRs%29.,in%20cancer%20research%20by%20the)). There is also interest in **CAR T-cell therapy** against MUC1: chimeric antigen receptor T-cells engineered to attack MUC1-positive cancers. Given the widespread expression of MUC1 in tumors, several CAR T constructs have been designed. For instance, a fully human CAR T (designated P-MUC1C-ALLO1) targeting the MUC1-C core is currently in a phase I trial for solid tumors ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20TG4010%20%20%7C%20MUC1,22)). Early preclinical data suggest that MUC1-specific CAR T cells can selectively kill carcinoma cells while sparing normal cells that have MUC1 mostly sequestered on the apical side or with different glycosylation. 

Beyond cancer, understanding MUC1’s function has implications in other diseases. A striking example is **MUC1-associated familial kidney disease**: certain mutations in MUC1 (frameshifts in the VNTR region) cause a misfolded protein that accumulates in kidney tubule cells, leading to medullary cystic kidney disease type 1 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11)). This illustrates that proper MUC1 processing is important for cell health. Additionally, because MUC1 modulates inflammation, it is being studied in chronic inflammatory diseases of mucosal organs. Variants in MUC1 have been examined for associations with **inflammatory bowel disease** and **respiratory conditions**, though these areas are still emerging.

In summary, MUC1’s **primary functions** are to serve as a **protective mucosal barrier and a modulator of signaling** in epithelial cells. It carries out these roles at the **cell surface** (providing a shield and interacting with pathogens) and at the **intracellular level** (transducing signals via its cytoplasmic tail). In normal physiology, MUC1 protects tissues from infection and regulates inflammation, while maintaining epithelial integrity. In pathological states like cancer, MUC1 is co-opted to promote tumor growth and metastasis. Its ubiquitous overexpression in carcinomas and distinct tumor-associated forms have made it both a **diagnostic marker** and a **target for immunotherapy** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=participates%20in%20epithelial%20cell%20renewal,This%20article%20reviews%20the)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC)). Ongoing research (as of 2023–2024) continues to uncover new aspects of MUC1 biology – such as its role in immune evasion and epigenetic regulation in cancer ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=associated%20MUC1%20,25)) – and to harness this knowledge in developing **MUC1-targeted treatments** to improve patient outcomes. 

**References:**

1. Chen X. *et al.* (2024). *MUC1 and MUC16: critical for immune modulation in cancer therapeutics*. Front. Immunol. **15**:1356913. DOI:10.3389/fimmu.2024.1356913 ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition)) ([www.frontiersin.org](https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also))

2. Dhar P, McAuley J. (2019). *The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation*. Front. Cell. Infect. Microbiol. **9**:117. DOI:10.3389/fcimb.2019.00117 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by))

3. Long L. *et al.* (2023). *The research status and prospects of MUC1 in immunology*. Hum. Vaccin. Immunother. **19**(1):2172278. DOI:10.1080/21645515.2023.2172278 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14))

4. Mao W. *et al.* (2024). *Research progress of MUC1 in genitourinary cancers*. Cell. Mol. Biol. Lett. **29**:135. DOI:10.1186/s11658-024-00654-x ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy))

5. McAuley JL. *et al.* (2007). *MUC1 cell surface mucin is a critical element of the mucosal barrier to infection*. J. Clin. Invest. **117**(8):2313–2324. DOI:10.1172/JCI26705 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016))

6. Kato K. *et al.* (2012). *MUC1: The first mammalian membrane-tethered mucin to be implicated in tumor suppression.* Mucosal Immunol. **5**(3):309–320. DOI:10.1038/mi.2012.9 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in))

7. Gnemmi V. *et al.* (2014). *MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma-secretase-dependent pathway*. Oncotarget **5**(3):754–765. DOI:10.18632/oncotarget.1776 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells))

8. Leng Y. *et al.* (2007). *Nucleocytoplasmic shuttling of MUC1 cytoplasmic tail: a novel mechanism for signal transduction and transcriptional regulation*. Biochem. Biophys. Res. Commun. **360**(1):145–150. DOI:10.1016/j.bbrc.2007.06.049 ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007))

9. Ueno K. *et al.* (2008). *MUC1 mucin is a negative regulator of TLR signaling*. Am. J. Respir. Cell Mol. Biol. **38**(3):263–268. DOI:10.1165/rcmb.2007-0078OC ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating))

10. Yamamoto M. *et al.* (1997). *MUC1 cytoplasmic domain mediates binding to beta-catenin*. J. Biol. Chem. **272**(16):12492–12494. DOI:10.1074/jbc.272.16.12492 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al))



## Citations

1. AnnotationURLCitation(end_index=416, start_index=296, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')
2. AnnotationURLCitation(end_index=818, start_index=701, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')
3. AnnotationURLCitation(end_index=1022, start_index=905, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')
4. AnnotationURLCitation(end_index=1258, start_index=1134, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%2C%20which%20is%20localized%20to,C')
5. AnnotationURLCitation(end_index=1620, start_index=1459, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')
6. AnnotationURLCitation(end_index=1791, start_index=1621, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of')
7. AnnotationURLCitation(end_index=2106, start_index=1950, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')
8. AnnotationURLCitation(end_index=2248, start_index=2107, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=amino%20acids%20in%20length%2C%20tethers,kinase%20%28Kato%20et')
9. AnnotationURLCitation(end_index=2637, start_index=2467, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of')
10. AnnotationURLCitation(end_index=2800, start_index=2638, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')
11. AnnotationURLCitation(end_index=3071, start_index=2952, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000')
12. AnnotationURLCitation(end_index=3406, start_index=3248, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')
13. AnnotationURLCitation(end_index=3517, start_index=3407, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
14. AnnotationURLCitation(end_index=3867, start_index=3737, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20polymorphic%20transmembrane,1')
15. AnnotationURLCitation(end_index=4005, start_index=3868, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=determines%20the%20speciffic%20spatial%20structure,8')
16. AnnotationURLCitation(end_index=4376, start_index=4254, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4')
17. AnnotationURLCitation(end_index=4673, start_index=4537, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC16%2C%20MUC17%2C%20MUC21%2C%20and%20MUC22%29.,12')
18. AnnotationURLCitation(end_index=4794, start_index=4674, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')
19. AnnotationURLCitation(end_index=4994, start_index=4872, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4')
20. AnnotationURLCitation(end_index=5892, start_index=5754, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Ligtenberg%20et%20al,2004%3B%20Thathiah%20and%20Carson')
21. AnnotationURLCitation(end_index=6002, start_index=5893, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=TNF,Lind%C3%A9n%20et%20al')
22. AnnotationURLCitation(end_index=6346, start_index=6247, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%29,2000')
23. AnnotationURLCitation(end_index=6654, start_index=6503, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')
24. AnnotationURLCitation(end_index=6808, start_index=6655, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells')
25. AnnotationURLCitation(end_index=7120, start_index=6969, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')
26. AnnotationURLCitation(end_index=7258, start_index=7121, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')
27. AnnotationURLCitation(end_index=7950, start_index=7846, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11')
28. AnnotationURLCitation(end_index=8113, start_index=7951, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition')
29. AnnotationURLCitation(end_index=8557, start_index=8461, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Introduction')
30. AnnotationURLCitation(end_index=8646, start_index=8558, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,9')
31. AnnotationURLCitation(end_index=8950, start_index=8791, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20family%20of%20cell%20surface,may%20play%20an%20important%20biological')
32. AnnotationURLCitation(end_index=9105, start_index=8951, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20all%20of%20the,The%20extracellular%20region%20that%20is')
33. AnnotationURLCitation(end_index=9583, start_index=9424, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=surface%20by%20nearly%20all%20epithelial,most%20extensively%20studied%20of%20the')
34. AnnotationURLCitation(end_index=9745, start_index=9584, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=environment%2C%20MUC1%20has%20been%20demonstrated,mucin%20regulates%20inflammation')
35. AnnotationURLCitation(end_index=10082, start_index=9920, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')
36. AnnotationURLCitation(end_index=10193, start_index=10083, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Thathiah%20et%20al,2009')
37. AnnotationURLCitation(end_index=10544, start_index=10426, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%3B%20Vinall%20et%20al,2007')
38. AnnotationURLCitation(end_index=10667, start_index=10545, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')
39. AnnotationURLCitation(end_index=11175, start_index=11027, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al')
40. AnnotationURLCitation(end_index=11382, start_index=11176, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=gastrointestinal%20and%20systemic%20spread%20of,another%20gastrointestinal%20pathogen%2C%20enteroaggregative%20Escherichia')
41. AnnotationURLCitation(end_index=11837, start_index=11726, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Wotherspoon%20et%20al,ED')
42. AnnotationURLCitation(end_index=11960, start_index=11838, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')
43. AnnotationURLCitation(end_index=12486, start_index=12318, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection')
44. AnnotationURLCitation(end_index=12936, start_index=12750, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')
45. AnnotationURLCitation(end_index=13228, start_index=13042, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')
46. AnnotationURLCitation(end_index=13605, start_index=13437, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection')
47. AnnotationURLCitation(end_index=13770, start_index=13606, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1')
48. AnnotationURLCitation(end_index=14432, start_index=14264, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')
49. AnnotationURLCitation(end_index=15149, start_index=14981, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')
50. AnnotationURLCitation(end_index=15303, start_index=15150, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,studies%20have%20shown%20that%20MUC1')
51. AnnotationURLCitation(end_index=15995, start_index=15828, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy')
52. AnnotationURLCitation(end_index=16231, start_index=15996, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
53. AnnotationURLCitation(end_index=16674, start_index=16439, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
54. AnnotationURLCitation(end_index=16901, start_index=16675, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=interactions%20with%20cell%20surface%20receptors,monoclonal%20antibody%20TAB004%20overcomes%20anoikis')
55. AnnotationURLCitation(end_index=17644, start_index=17534, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
56. AnnotationURLCitation(end_index=18131, start_index=17977, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')
57. AnnotationURLCitation(end_index=18424, start_index=18270, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')
58. AnnotationURLCitation(end_index=18926, start_index=18722, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=extracellular%20domain%2C%20a%2028,cancer%20cases%20exhibiting%20its%20abnormal')
59. AnnotationURLCitation(end_index=19109, start_index=18927, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=MUC1%20serves%20as%20a%20protective,C%20participates%20in')
60. AnnotationURLCitation(end_index=19417, start_index=19269, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,a%20crucial%20role%20in%20RCC')
61. AnnotationURLCitation(end_index=20148, start_index=19990, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')
62. AnnotationURLCitation(end_index=20259, start_index=20149, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
63. AnnotationURLCitation(end_index=20801, start_index=20694, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2001a%20%29%3B%20PLC,29')
64. AnnotationURLCitation(end_index=21021, start_index=20879, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al')
65. AnnotationURLCitation(end_index=21317, start_index=21175, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al')
66. AnnotationURLCitation(end_index=21691, start_index=21528, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing')
67. AnnotationURLCitation(end_index=21811, start_index=21692, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing')
68. AnnotationURLCitation(end_index=22079, start_index=21979, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=protein%20kinase,2007')
69. AnnotationURLCitation(end_index=22664, start_index=22554, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
70. AnnotationURLCitation(end_index=22892, start_index=22782, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
71. AnnotationURLCitation(end_index=23314, start_index=23204, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
72. AnnotationURLCitation(end_index=23469, start_index=23315, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')
73. AnnotationURLCitation(end_index=23841, start_index=23687, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')
74. AnnotationURLCitation(end_index=24274, start_index=24137, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')
75. AnnotationURLCitation(end_index=24575, start_index=24438, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')
76. AnnotationURLCitation(end_index=25538, start_index=25313, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can')
77. AnnotationURLCitation(end_index=25710, start_index=25539, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=promoting%20its%20degradation%20%2817%20%29,25')
78. AnnotationURLCitation(end_index=26207, start_index=26062, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=Blue%20bars%20mark%20the%20known,the%20CT%20contains%20the%20motif')
79. AnnotationURLCitation(end_index=26634, start_index=26476, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')
80. AnnotationURLCitation(end_index=26745, start_index=26635, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')
81. AnnotationURLCitation(end_index=27071, start_index=26984, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')
82. AnnotationURLCitation(end_index=27277, start_index=27190, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')
83. AnnotationURLCitation(end_index=28400, start_index=28238, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
84. AnnotationURLCitation(end_index=28527, start_index=28401, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=inflammation,with%20TLRs%20at%20the%20cell')
85. AnnotationURLCitation(end_index=29001, start_index=28855, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell')
86. AnnotationURLCitation(end_index=29167, start_index=29002, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell')
87. AnnotationURLCitation(end_index=29591, start_index=29428, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing')
88. AnnotationURLCitation(end_index=29754, start_index=29592, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
89. AnnotationURLCitation(end_index=30061, start_index=29899, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
90. AnnotationURLCitation(end_index=30204, start_index=30062, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
91. AnnotationURLCitation(end_index=30519, start_index=30400, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing')
92. AnnotationURLCitation(end_index=30662, start_index=30520, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
93. AnnotationURLCitation(end_index=31058, start_index=30895, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney')
94. AnnotationURLCitation(end_index=31163, start_index=31059, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence')
95. AnnotationURLCitation(end_index=31521, start_index=31358, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney')
96. AnnotationURLCitation(end_index=31626, start_index=31522, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence')
97. AnnotationURLCitation(end_index=32035, start_index=31889, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the')
98. AnnotationURLCitation(end_index=32145, start_index=32036, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')
99. AnnotationURLCitation(end_index=32411, start_index=32280, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=including%20Pam_,CT%20is%20required%20for%20the')
100. AnnotationURLCitation(end_index=32729, start_index=32620, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')
101. AnnotationURLCitation(end_index=32873, start_index=32730, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Kato%20et%20al,role%20in%20controlling%20disease%20severity')
102. AnnotationURLCitation(end_index=33261, start_index=33102, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=formation%20of%20the%20inflammasome%20complex,as%20the%20NLRP%2C%20or%20the')
103. AnnotationURLCitation(end_index=33375, start_index=33262, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Figure%202B%29,Figure%202C')
104. AnnotationURLCitation(end_index=33847, start_index=33701, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell')
105. AnnotationURLCitation(end_index=34013, start_index=33848, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell')
106. AnnotationURLCitation(end_index=34468, start_index=34282, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')
107. AnnotationURLCitation(end_index=34633, start_index=34469, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1')
108. AnnotationURLCitation(end_index=34993, start_index=34874, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000')
109. AnnotationURLCitation(end_index=35726, start_index=35491, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
110. AnnotationURLCitation(end_index=36048, start_index=35813, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
111. AnnotationURLCitation(end_index=36641, start_index=36468, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=In%20cancer%20cells%2C%20the%20long,Friedenreich%2C%20CD176%2C%20T%20antigen%29%2C%20and')
112. AnnotationURLCitation(end_index=36746, start_index=36642, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,10%E2%80%9312')
113. AnnotationURLCitation(end_index=37255, start_index=37129, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC')
114. AnnotationURLCitation(end_index=37603, start_index=37463, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,pancreatic%20ductal%20carcinoma%2C%20and%20thymic')
115. AnnotationURLCitation(end_index=37944, start_index=37716, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable')
116. AnnotationURLCitation(end_index=38180, start_index=37945, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
117. AnnotationURLCitation(end_index=38633, start_index=38405, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable')
118. AnnotationURLCitation(end_index=38859, start_index=38634, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can')
119. AnnotationURLCitation(end_index=39170, start_index=39023, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=strong%20antitumor%20effects,in%20cancer%20research%20by%20the')
120. AnnotationURLCitation(end_index=39807, start_index=39688, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199')
121. AnnotationURLCitation(end_index=39984, start_index=39808, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=In%20recent%20years%2C%20new%20discoveries,manner%2C%20with%20objective%20remission%20being')
122. AnnotationURLCitation(end_index=40374, start_index=40233, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=TG4010%20is%20a%20cancer%20vaccine,In%20metastatic%20RCC')
123. AnnotationURLCitation(end_index=40543, start_index=40375, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=telomerase%2C%20survivin%2C%20and%20MAGE,like%20receptor%209%20%28TLR9%29%20agonist')
124. AnnotationURLCitation(end_index=40913, start_index=40764, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=detected%20in%20the%2011%20patients,133%5D%20demonstrated%20that')
125. AnnotationURLCitation(end_index=41045, start_index=40914, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=CD4,like%20receptor%209%20%28TLR9%29%20agonist')
126. AnnotationURLCitation(end_index=41490, start_index=41313, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=development%20of%20research%20strategies%20targeting,patients%20with%20metastatic%20RCC%20to')
127. AnnotationURLCitation(end_index=41648, start_index=41491, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%28DC,A1%29%20using%20adjuvant%20granulocyte%E2%80%93macrophage%20colony')
128. AnnotationURLCitation(end_index=42063, start_index=41944, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199')
129. AnnotationURLCitation(end_index=42170, start_index=42064, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20CAR,NCT00852007')
130. AnnotationURLCitation(end_index=42700, start_index=42491, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=stemness%20of%20cancer%20cells%2C%20primarily,As%20an%20oncogenic%20driver%2C%20MUC1')
131. AnnotationURLCitation(end_index=43006, start_index=42856, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=tandem%20repeats%20%28VNTRs%29.,in%20cancer%20research%20by%20the')
132. AnnotationURLCitation(end_index=43497, start_index=43381, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20TG4010%20%20%7C%20MUC1,22')
133. AnnotationURLCitation(end_index=44141, start_index=44037, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11')
134. AnnotationURLCitation(end_index=45368, start_index=45205, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=participates%20in%20epithelial%20cell%20renewal,This%20article%20reviews%20the')
135. AnnotationURLCitation(end_index=45495, start_index=45369, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC')
136. AnnotationURLCitation(end_index=45889, start_index=45654, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
137. AnnotationURLCitation(end_index=46038, start_index=45890, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=associated%20MUC1%20,25')
138. AnnotationURLCitation(end_index=46488, start_index=46326, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition')
139. AnnotationURLCitation(end_index=46724, start_index=46489, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')
140. AnnotationURLCitation(end_index=47088, start_index=46927, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')
141. AnnotationURLCitation(end_index=47251, start_index=47089, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')
142. AnnotationURLCitation(end_index=47535, start_index=47418, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')
143. AnnotationURLCitation(end_index=47656, start_index=47536, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')
144. AnnotationURLCitation(end_index=47973, start_index=47805, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')
145. AnnotationURLCitation(end_index=48141, start_index=47974, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy')
146. AnnotationURLCitation(end_index=48468, start_index=48320, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al')
147. AnnotationURLCitation(end_index=48591, start_index=48469, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')
148. AnnotationURLCitation(end_index=48931, start_index=48769, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
149. AnnotationURLCitation(end_index=49074, start_index=48932, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')
150. AnnotationURLCitation(end_index=49441, start_index=49290, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')
151. AnnotationURLCitation(end_index=49595, start_index=49442, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells')
152. AnnotationURLCitation(end_index=49924, start_index=49837, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')
153. AnnotationURLCitation(end_index=50234, start_index=50088, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the')
154. AnnotationURLCitation(end_index=50344, start_index=50235, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')
155. AnnotationURLCitation(end_index=50618, start_index=50508, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')